LEADER 02623nam 2200601 450 001 9910818127403321 005 20170822131652.0 010 $a1-4704-0228-9 035 $a(CKB)3360000000464823 035 $a(EBL)3114428 035 $a(SSID)ssj0000889238 035 $a(PQKBManifestationID)11482813 035 $a(PQKBTitleCode)TC0000889238 035 $a(PQKBWorkID)10875862 035 $a(PQKB)10364148 035 $a(MiAaPQ)EBC3114428 035 $a(RPAM)3086392 035 $a(PPN)19541523X 035 $a(EXLCZ)993360000000464823 100 $a19980406d1998 uy| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aStructurally stable quadratic vector fields /$fJoan C. Arte?s, Robert E. Kooij, Jaume Llibre 210 1$aProvidence, Rhode Island :$cAmerican Mathematical Society,$d1998. 215 $a1 online resource (122 p.) 225 1 $aMemoirs of the American Mathematical Society,$x0065-9266 ;$vnumber 639 300 $a"July 1998, volume 134, number 639 (fifth of 6 numbers)." 311 $a0-8218-0796-X 320 $aIncludes bibliographical references. 327 $a""Contents""; ""Chapter 1. Introduction""; ""Chapter 2. Preliminary Definitions""; ""Chapter 3. Structural Stability Theorems""; ""Chapter 4. Some Preliminary Tools""; ""Chapter 5. Proof of Theorem 1.1(a)""; ""5.1 Introduction""; ""5.2 Case 7""; ""5.3 Case 9""; ""5.4 Case 10""; ""5.4.1 Case 10 A""; ""5.4.2 Case 10 B""; ""5.5 Case 12""; ""5.5.1 Case 12 A""; ""5.5.2 Case 12 B""; ""5.6 Classes that are not realizable""; ""5.7 Final Classification""; ""Chapter 6. Proof of Theorem 1.1(b)""; ""6.1 Introduction""; ""6.2 Realization of cases previously known""; ""6.3 Proof of Proposition 5.13"" 327 $a""6.4 Numerical examples""""Chapter 7. Proofs of Theorems 1.2, 1.3 and 1.4""; ""Chapter 8. Structural Stability and the Parameter Space""; ""Bibliography"" 410 0$aMemoirs of the American Mathematical Society ;$vno. 639. 606 $aDifferential equations$xNumerical solutions 606 $aStability 606 $aVector fields 615 0$aDifferential equations$xNumerical solutions. 615 0$aStability. 615 0$aVector fields. 676 $a510 s 676 $a515/.35 700 $aArte?s$b Joan C.$f1961-$0501630 702 $aKooij$b Robert E.$f1963- 702 $aLlibre$b Jaume 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818127403321 996 $aStructurally stable quadratic vector fields$94037039 997 $aUNINA LEADER 04681nam 2201453z- 450 001 9910557648103321 005 20210501 035 $a(CKB)5400000000044972 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69291 035 $a(oapen)doab69291 035 $a(EXLCZ)995400000000044972 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aKilling Cancer$eDiscovery and Selection of New Target Molecules 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (302 p.) 311 08$a3-03943-440-3 311 08$a3-03943-441-1 330 $aDespite the efficiency of current cancer treatments, cancer is still a deadly disease for too many. In 2008, 7.6 million people died of cancer; with the current development, it is estimated that the annual cancer death number will grow to 13 million by 2030. There is clearly a need for not only more research but also more innovative and out of the mainstream scientific ideas to discover and develop even better cancer treatments. This book presents the collective works published in the recent Special Issue entitled "Killing Cancer: Discovery and Selection of New Target Molecules". These articles comprise a selection of studies, ideas, and opinions that aim to facilitate knowledge, thoughts, and discussion about which biological and molecular mechanisms in cancer we should target and how we should target them. 517 $aKilling Cancer 606 $aBiology, life sciences$2bicssc 606 $aResearch & information: general$2bicssc 610 $a3D growth 610 $aABCG2 610 $aAF1Q 610 $aanoikis 610 $aATP-binding cassette transporter 610 $aATP6V0a3 610 $aATR pathway 610 $aautophagy 610 $aBRCA1 610 $aBRCA2 610 $abreast cancer resistance protein (BCRP) 610 $abreast cancer stem cells 610 $aC2 domain 610 $acancer 610 $acancer metabolism 610 $acancer therapy 610 $aCD domain 610 $achondroitin sulfate 610 $acolorectal cancer 610 $adexamethasone 610 $adisulfiram 610 $aDNA damage 610 $adrug efflux pumps 610 $adysferlin 610 $aEMT 610 $aepithelial-mesenchymal transition 610 $aERK1 610 $aERK2 610 $aesophageal cancer 610 $aferlin 610 $aglucocorticoids 610 $aIL-8 610 $aimmunotherapy 610 $ainflammation 610 $ainvasion 610 $akinase inhibitors 610 $alysosome 610 $alysosome-mediated invasion 610 $amammosphere 610 $aMAPK kinase 610 $amatrix degradation 610 $ametabolism 610 $amicrogravity 610 $amicrosatellite instability 610 $amigration 610 $aMLLT11 610 $amTOR in immunotherapy 610 $amTOR inhibitors 610 $amTOR signaling 610 $amTORC1 610 $amTORC2 610 $amultidrug resistance in cancer 610 $amyoferlin 610 $aMZF1 610 $an/a 610 $aNF-?B 610 $aNPL4 610 $anuclear factor kappa-light-chain-enhancer of activated B-cells (NF-?B) 610 $anutrient metabolism 610 $aoncofetal chondroitin sulfate 610 $aotoferlin 610 $aPAK4 610 $aPDAC 610 $apediatric cancer 610 $apH-regulation 610 $aphosphorylation 610 $aplasma membrane 610 $aprognosis 610 $aproliferation 610 $apyrazolo-pyrimidine derivative 610 $arapalogs 610 $areplication stress 610 $aRolled 610 $aSCH772984 610 $aSCO-201 610 $asevenmaker 610 $asolid tumors 610 $aspace environment 610 $aSTAT 610 $asulconazole 610 $aSUMOylation 610 $atarget 610 $atargeted cancer therapy 610 $aTCIRG1 610 $athyroid cancer 610 $atranscription factor 610 $aVAR2 610 $aVRT-11E 610 $aWNT 610 $azinc finger 615 7$aBiology, life sciences 615 7$aResearch & information: general 700 $aKallunki$b Tuula$4edt$01300030 702 $aKallunki$b Tuula$4oth 906 $aBOOK 912 $a9910557648103321 996 $aKilling Cancer$93025349 997 $aUNINA